OHSU

IRB #

IRB00006168

Title

Catheter Ablation Versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial

Principal Investigator

Jack Kron

Study Purpose

The purpose of this study is to compare drug therapy and catheter ablation in patients with afib (an abnormal, rapid heart rhythm coming from the upper chambers of the heart). Drug therapy is designed to stop the abnormal rhythm and maintain normal beating. Catheter ablation is a procedure using catheters, or tubes, inserted into the blood vessels of the heart to eliminate the triggers that start periods of afib or stop the conditions that keep it going.

Medical Condition(s)

Afib
Keyword: cardiovascular

Eligibility Criteria

-Age 65+ (or younger than 65 with one or more risk factors for stroke)
-Warrant active afib therapy (within the past 3 months) beyond simple ongoing observation

Age Range

18 - 100

Healthy Volunteers Needed

No

Duration of Participation

About 5 years

Minors Included

No

Contact

Liz Cannard
(503) 494-5893

Sponsor

National Heart, Lung and Blood Institute (NHLBI)

Recruitment End

01/29/2016

Compensation Provided

No


Go Back